Clinical Trials Browser

Lung Neoplasms × Hematologic Tests × Clear all

NCT06620835 2026-04-29

OPTALK

Phase 2 Recruiting

Lung Neoplasms

NCT03654105 2026-03-27

SMILE

Phase 2 Active not recruiting

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT05766046 2026-03-27

RISP

Phase NA Active not recruiting

Cardiovascular Diseases, Lung Neoplasms, Smoking Cessation, Pulmonary Disease, Chronic Obstructive

NCT06717295 2026-01-02

CCANED-CIPHER

CNSGastrointestinalGenitourinaryGynecologicThoracic

Pancreatic cancer, adult, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06341387 2024-04-02

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms

NCT03645317 2021-08-02

ACCOLADE

Phase NA Unknown

Lung Neoplasms

NCT02839681 2019-05-21

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

Phase 2 Terminated

2 enrolled 12 charts

Adenocarcinoma of Lung, Lung Neoplasms

NCT01604642 2018-04-02

Role of Activin A (ActA) in the Human Cancer Cachexia

Phase NA Completed

GastrointestinalThoracic

Lung Neoplasms, Colorectal Neoplasms

NCT01687647 2014-04-09

AMORCE-CBP

Phase 3 Unknown

Lung Neoplasms

NCT02090166 2014-03-18

EDLC

Phase NA Unknown

Lung Neoplasms